US4076804A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Erythromycin therapy
Assignee: Abbott Laboratories
•
Filing: 1976-12-13
•
Granted: 1978-02-28
•
Expires: 1996-12-13
Abstract
Abstract This invention is directed to the method of combatting erythromycin sensitive bacteria in warm-blooded animals without restricting their food intake.
Inventors
- 👤 Robert E. Singiser
- 👤 Alexander Hing Chinn Chun
- 👤 Shashi Pal Mehta
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 14:10
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A61K31/00; A61K31/70; A61K9/0012; A61K9/0053; A61K9/0056
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
59 words
The process of combatting an erythromycin sensitive infection in a warm-blooded animal in non-fasting condition, comprising, administering to said animal a pharmaceutical preparation of erythromycin ethylsuccinate in granulated form, said granules comprising per 100 parts of erythromycin ethylsuccinate between 3 and 100 parts of a pharmaceutically acceptable gum and between 20 and 4000 parts of a physiologically acceptable sugar.
Claim 2
Dependent Claim
59 words
The process of combatting an erythromycin sensitive infection in a warm-blooded animal in non-fasting condition, comprising, administering to said animal a pharmaceutical preparation of erythromycin ethylsuccinate in granulated form, said granules comprising per 100 parts of erythromycin ethylsuccinate between 3 and 100 parts of a pharmaceutically acceptable gum and between 20 and 4000 parts of a physiologically acceptable sugar.
Claim 3
Dependent Claim
16 words
The process of claim 1 wherein said granules are administered in the form of a suspension.
Claim 4
Dependent Claim
17 words
The process of claim 1 wherein said granules are administered in the form of a chewable tablet.
Claim 5
Dependent Claim
53 words
A chewable tablet consisting essentially of granules, consisting essentially of 100 parts by weight of erythromycin ethylsuccinate, 3-100 parts by weight of a pharmaceutically acceptable gum and 20-4000 parts by weight of a physiologically acceptable sugar, said sugar being used in powderd form containing essentially no particles with a diameter > 150 microns.
Claim 6
Dependent Claim
53 words
A chewable tablet consisting essentially of granules, consisting essentially of 100 parts by weight of erythromycin ethylsuccinate, 3-100 parts by weight of a pharmaceutically acceptable gum and 20-4000 parts by weight of a physiologically acceptable sugar, said sugar being used in powderd form containing essentially no particles with a diameter > 150 microns.
References Cited (Backward Citations)
US3878192A
Cited
US3865935A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-02-27 | 1981-08-29 | 1982-02-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-02-27 | 1985-08-29 | 1986-02-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-02-27 | 1989-08-29 | 1990-02-28 | $7700.00 | Window Closed / Lapsed |